Oncobiologics Mutual Funds

Health Care & Life Sciences » Biotechnology | Oncobiologics Inc.

Oncobiologics Inc. | Mutual Funds

Name

Shares Held

% Shares Out

Change In Shares

% of Assets

As of Date

Vanguard Total Stock Market Index Fund

294,705

0.41%

07/31/2018

Bridgeway Ultra Small Company Market Fund

113,000

0.16%

0.02%

12/31/2017

Vanguard Extended Market Index Fund

12,746

0.02%

07/31/2018

Fidelity Nasdaq Composite Index

11,165

0.02%

07/31/2018

6,018

0.01%

0.02%

09/05/2018

AXA/Lord Abbett Micro Cap Portfolio

2,465

03/31/2018

Vanguard Balanced Index Fund

1,586

07/31/2018

View Profile

Address	7 Clarke Drive Cranbury New Jersey 08512 United States
Employees	-
Website	http://www.oncobiologics.com
Updated	09/14/2018
Oncobiologics, Inc. is a clinical-stage biopharmaceutical company, which focuses on the identification, development, manufacture, and commercialization of complex biosimilar therapeutics. It focuses on monoclonal antibodies, in the disease areas of immunology and oncology. The company was founded by Pankaj Mohan on January 5, 2010 and is headquartered in Cranbury, NJ.